CRISPR Gene Editing shown to be effective in improving vision
May 20, 2024Boston, Mass. — Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated. The phase 1/2 trial called BRILLIANCE, was led by principal investigator Read More
Knights Templar Eye Foundation 2024- 2025 Career Starter Grants
May 2, 2024Ocular Genomics Institute members Hanmeng Zhang, Egle Galdikatie-Braziene, and Kannan Manian were awarded support for their work. Hanmeng Zhang, PhD: Investigating the role... Read More